Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Combretastatin A 4. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of CA-4 derivatives via patent CN102219811A. Offers improved solubility and supply chain reliability for pharmaceutical manufacturing.
Patent CN1266104C details a cost-effective route to (Z)-3'-hydroxy-3,4,4',5-tetramethoxy diphenyl ethylene using cheap homoanisic acid, offering significant supply chain advantages.
Discover the polymer-supported synthesis of Combretastatin A-4 via patent CN100343216C. Achieve high Z-selectivity and simplified purification for scalable pharmaceutical manufacturing.
Patent CN101220054A reveals a mild DMAP-catalyzed phosphorylation route for Combretastatin A-4 phosphate, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Wittig condensation and iron reduction process for high-purity combretastatin intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.